Importantly, efpeglenatides immunogenicity remained relatively low, with few patients developing clinically significant anti-drug antibodies, allowing its safety profile to be viewed as manageable within class expectations
Increased Risk of Low Blood Sugar (Even in Non-Diabetics) GLP-1 meds lower glucose
Meet Pep a free, easy-to-use GLP-1 tracker built specifically for people using Ozempic, Wegovy, Mounjaro, Zepbound, and oral GLP-1 medications for weight loss, diabetes, or metabolic health
Whether you are a type-2 diabetic who has been prescribed Ozempic to help you to manage blood sugar levels, or are obese and taking Mounjaro or Wegovy for for weight loss and weight management, medics are warning revellers to be cautious about drinking alcohol while taking GLP-1 receptor agonist drugs this festive season
In addition, GLP-1 RAs have been identified as an important drug class for not only glucose-lowering but also in reducing cardiovascular disease (CVD) events in adults with T2DM and high atherosclerotic cardiovascular disease (ASCVD) risk.1 GLP-1 RAs stimulate glucose-dependent insulin release in the gut after food intake and inhibit glucagon release with concomitant decreased gastric emptying and low risk of hypoglycemia
